186 related articles for article (PubMed ID: 33802702)
1. Anti-Cancer Effects and Tumor Marker Role of Glutathione
Jou YC; Wang SC; Dia YC; Wang ST; Yu MH; Yang HY; Chen LC; Shen CH; Liu YW
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33802702
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic regulation of human WIF1 and DNA methylation situation of WIF1 and GSTM5 in urothelial carcinoma.
Shen CH; Li PY; Wang SC; Wu SR; Hsieh CY; Dai YC; Liu YW
Heliyon; 2023 May; 9(5):e16004. PubMed ID: 37206019
[TBL] [Abstract][Full Text] [Related]
3. Aberrant expression of GSTM5 in lung adenocarcinoma is associated with DNA hypermethylation and poor prognosis.
Hao X; Zhang J; Chen G; Cao W; Chen H; Chen S
BMC Cancer; 2022 Jun; 22(1):685. PubMed ID: 35729618
[TBL] [Abstract][Full Text] [Related]
4. Gene Expression and DNA Methylation Status of Glutathione S-Transferase Mu1 and Mu5 in Urothelial Carcinoma.
Wang SC; Huang CC; Shen CH; Lin LC; Zhao PW; Chen SY; Deng YC; Liu YW
PLoS One; 2016; 11(7):e0159102. PubMed ID: 27404495
[TBL] [Abstract][Full Text] [Related]
5. Multifactorial involvement of multidrug resistance-associated [correction of resistance] protein, DNA topoisomerase II and glutathione/glutathione-S-transferase in nonP-glycoprotein-mediated multidrug resistance in human bladder cancer cells.
Kim WJ; Kakehi Y; Yoshida O
Int J Urol; 1997 Nov; 4(6):583-90. PubMed ID: 9477189
[TBL] [Abstract][Full Text] [Related]
6. Inactivation of ADAMTS18 by aberrant promoter hypermethylation contribute to lung cancer progression.
Zhang Y; Xu H; Mu J; Guo S; Ye L; Li D; Peng W; He X; Xiang T
J Cell Physiol; 2019 May; 234(5):6965-6975. PubMed ID: 30417422
[TBL] [Abstract][Full Text] [Related]
7. CpG hypermethylation of collagen type I alpha 2 contributes to proliferation and migration activity of human bladder cancer.
Mori K; Enokida H; Kagara I; Kawakami K; Chiyomaru T; Tatarano S; Kawahara K; Nishiyama K; Seki N; Nakagawa M
Int J Oncol; 2009 Jun; 34(6):1593-602. PubMed ID: 19424577
[TBL] [Abstract][Full Text] [Related]
8. The suppressive role of phytochemical-induced glutathione S-transferase Mu 2 in human urothelial carcinoma cells.
Shen CH; Wu JY; Wang SC; Wang CH; Hong CT; Liu PY; Wu SR; Liu YW
Biomed Pharmacother; 2022 Jul; 151():113102. PubMed ID: 35594716
[TBL] [Abstract][Full Text] [Related]
9. Histone Demethylase KDM7A Regulates Androgen Receptor Activity, and Its Chemical Inhibitor TC-E 5002 Overcomes Cisplatin-Resistance in Bladder Cancer Cells.
Lee KH; Kim BC; Jeong SH; Jeong CW; Ku JH; Kim HH; Kwak C
Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32781788
[TBL] [Abstract][Full Text] [Related]
10. Mitomycin C sensitivity in human bladder cancer cells: possible role of glutathione and glutathione transferase in resistance.
Xu BH; Gupta V; Singh SV
Arch Biochem Biophys; 1994 Jan; 308(1):164-70. PubMed ID: 8311448
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of cross-resistance to cisplatin in a mitomycin C-resistant human bladder cancer cell line.
Singh SV; Xu BH; Jani JP; Emerson EO; Backes MG; Rihn C; Scalamogna D; Stemmler N; Specht S; Blanock K
Int J Cancer; 1995 May; 61(3):431-6. PubMed ID: 7729958
[TBL] [Abstract][Full Text] [Related]
12. Gene expression and DNA methylation regulation of arsenic in mouse bladder tissues and in human urothelial cells.
Jou YC; Wang SC; Dai YC; Chen SY; Shen CH; Lee YR; Chen LC; Liu YW
Oncol Rep; 2019 Sep; 42(3):1005-1016. PubMed ID: 31322264
[TBL] [Abstract][Full Text] [Related]
13. TAp73 expression and P1 promoter methylation, a potential marker for chemoresponsiveness to cisplatin therapy and survival in muscle-invasive bladder cancer (MIBC).
Bunch B; Krishnan N; Greenspan RD; Ramakrishnan S; Attwood K; Yan L; Qi Q; Wang D; Morrison C; Omilian A; Bshara W; Pili R; Trump DL; Johnson C; Woloszynska A
Cell Cycle; 2019 Sep; 18(17):2055-2066. PubMed ID: 31318640
[TBL] [Abstract][Full Text] [Related]
14. Characterization of PHGDH expression in bladder cancer: potential targeting therapy with gemcitabine/cisplatin and the contribution of promoter DNA hypomethylation.
Yoshino H; Enokida H; Osako Y; Nohata N; Yonemori M; Sugita S; Kuroshima K; Tsuruda M; Tatarano S; Nakagawa M
Mol Oncol; 2020 Sep; 14(9):2190-2202. PubMed ID: 32386122
[TBL] [Abstract][Full Text] [Related]
15. alpha(v)beta(3) Integrin-mediated drug resistance in human laryngeal carcinoma cells is caused by glutathione-dependent elimination of drug-induced reactive oxidative species.
Brozovic A; Majhen D; Roje V; Mikac N; Jakopec S; Fritz G; Osmak M; Ambriovic-Ristov A
Mol Pharmacol; 2008 Jul; 74(1):298-306. PubMed ID: 18441044
[TBL] [Abstract][Full Text] [Related]
16. Enhanced expression of gamma-glutamylcysteine synthetase and glutathione S-transferase genes in cisplatin-resistant bladder cancer cells with multidrug resistance phenotype.
Kotoh S; Naito S; Yokomizo A; Kohno K; Kuwano M; Kumazawa J
J Urol; 1997 Mar; 157(3):1054-8. PubMed ID: 9072542
[TBL] [Abstract][Full Text] [Related]
17. Promoter methylation and downregulation of SLC22A18 are associated with the development and progression of human glioma.
Chu SH; Feng DF; Ma YB; Zhang H; Zhu ZA; Li ZQ; Jiang PC
J Transl Med; 2011 Sep; 9():156. PubMed ID: 21936894
[TBL] [Abstract][Full Text] [Related]
18. Effect of glutathione and its related enzymes on chemosensitivity of renal cell carcinoma and bladder carcinoma cell lines.
Ahn H; Lee E; Kim K; Lee C
J Urol; 1994 Jan; 151(1):263-7. PubMed ID: 8254825
[TBL] [Abstract][Full Text] [Related]
19. KRAB zinc-finger protein 382 regulates epithelial-mesenchymal transition and functions as a tumor suppressor, but is silenced by CpG methylation in gastric cancer.
Pei L; He X; Li S; Sun R; Xiang Q; Ren G; Xiang T
Int J Oncol; 2018 Sep; 53(3):961-972. PubMed ID: 29956735
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of glutathione S-transferase and elevation of thiol pools in a multidrug-resistant human colon cancer cell line.
Chao CC; Huang YT; Ma CM; Chou WY; Lin-Chao S
Mol Pharmacol; 1992 Jan; 41(1):69-75. PubMed ID: 1346333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
